CUBT (Curative Biotechnology) Common Stock: $0.06 Mil (As of Mar. 2023)


What is Curative Biotechnology Common Stock?

Curative Biotechnology CUBT +19.71% Common Stock is $0.06 Mil as of Mar. 2023.

Curative Biotechnology's quarterly common stock increased from Sep. 2022 ($0.00 Mil) to Dec. 2022 ($0.06 Mil) and increased from Dec. 2022 ($0.06 Mil) to Mar. 2023 ($0.06 Mil).

Curative Biotechnology's annual common stock increased from Dec. 2020 ($0.00 Mil) to Dec. 2021 ($0.06 Mil) and increased from Dec. 2021 ($0.06 Mil) to Dec. 2022 ($0.06 Mil).

Curative Biotechnology Common Stock Historical Data

* Premium members only.

The historical data trend for Curative Biotechnology's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curative Biotechnology Common Stock Chart

Curative Biotechnology Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Common Stock
Get a 7-Day Free Trial 0.32 0.32 0.00 0.06 0.06

Curative Biotechnology Quarterly Data
Dec16 Dec17 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.00 0.00 0.06 0.06

Curative Biotechnology Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.06 Mil mean?
Curative Biotechnology (CUBT) has a Common Stock of $0.06 Mil as of Mar. 2023. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Curative Biotechnology and its competitors.
Is Curative Biotechnology's Common Stock too high?
Curative Biotechnology's current Common Stock is $0.06 Mil.
How does Curative Biotechnology's Common Stock compare to ORGS and SNSE?
Curative Biotechnology's Common Stock of $0.06 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Curative Biotechnology and its competitors. Curative Biotechnology's current Common Stock is $0.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curative Biotechnology stock overvalued right now?
Curative Biotechnology (CUBT) has a current Common Stock of $0.06 Mil. The current Common Stock is $0.06 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Curative Biotechnology (CUBT), the current Common Stock is $0.06 Mil as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Curative Biotechnology Business Description

Address 3801 PGA Boulevard, Suite 600, Palm Beach Gardens, FL, USA, 33410
Curative Biotechnology Inc is a development-stage biomedical company focusing on novel treatments for rare diseases. The Company is identifying, acquiring, and developing disease-modifying therapeutic drug candidates with a concentration on rare disease indications. Curative Biotech currently has ongoing programs in three different therapeutic areas: degenerative eye disease, infectious disease, and neuro-oncology. The Company is now concentrating its energy and resources on its degenerative eye disease platform.